Search - tctmd.com

Displaying 961 - 980 of 2063

Sort: Relevancy | Date

News Conference News TCT 2015

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

OCT Feasible for Identifying Factors Related to Stent Thrombosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

News Daily News

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

L.A. McKeown

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Study Validates Safety of Tryton Stent

October 13, 2015

News Daily News

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

L.A. McKeown

October 13, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

October 12, 2015

Advertisement

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

OCT Feasible for Identifying Factors Related to Stent Thrombosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

Trial Results Often Struggle to Keep Pace With Evolving Technology

Study Validates Safety of Tryton Stent

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

Debaters Question Need for Further Stent Innovation

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Very Late Stent Thrombosis Remains an Important Clinical Target

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content